Jubilant Ingrevia has commissioned its new facility at its manufacturing site for Diketene derivatives at Gajraula, Uttar Pradesh. As a global, integrated life science products and innovative solutions provider, the company presently has over 134 products & innovative solutions commercialised. With over four decades of experience, it has developed proficiency across ~35 key chemistry and technology platforms across its businesses: specialty, nutrition and chemical intermediates.
Jubilant Ingrevia has announced a contract development and manufacturing organisation (CDMO) contract for an estimated value of Rs 270 crore in the speciality chemicals business, spanning over three years with one of its international customers. The company will supply two key GMP intermediates for one of the ‘patented drugs’ of the innovator pharma customer. Both these products involve seven steps of specialised chemistry.
Jubilant Ingrevia has announced a contract development and manufacturing organisation (CDMO) contract for an estimated value of Rs 270 crore in the speciality chemicals business, spanning over three years with one of its international customers. The company will supply two key GMP intermediates for one of the ‘patented drugs’ of the innovator pharma customer. Both these products involve seven steps of specialised chemistry.